RemeGen Co., Ltd. (REGMF)
9.96
0.00 (0.00%)
USD |
OTCM |
Oct 26, 16:00
RemeGen Price : 9.96 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 23, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 22, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 21, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 20, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 19, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 16, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 15, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 14, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 4300.00 |
| Oct 13, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 12, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 09, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 08, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 07, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 6500.00 |
| Oct 06, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 05, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 02, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Oct 01, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Sep 30, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Sep 29, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Sep 28, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Sep 25, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Sep 24, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Sep 23, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
| Sep 22, 2026 | 9.96 | 9.96 | 9.96 | 9.96 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 0.73 |
| CStone Pharmaceuticals Co. Ltd. | 0.7547 |
| InnoCare Pharma Ltd. | 1.60 |
| Adagene, Inc. | 2.58 |
| JW (Cayman) Therapeutics Co. Ltd. | 0.2022 |
Price Related Metrics
| PE Ratio | 6.60 |
| PS Ratio | 4.811 |
| Price to Book Value | 4.559 |
| Price to Free Cash Flow | 8.740 |
| Earnings Yield | 15.15% |
| Market Cap | 5.586B |
| Operating PE Ratio | 7.812 |
| Normalized PE Ratio | 7.443 |